Kenneth B. Lee Jr., Director at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 6,000 shares at $15.35 ($92K) on 2021-09-13, disclosed to the SEC on 2021-09-15.
Open-market sale of $92k BCRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| BCRX | BUY | 2019-11-18 | $7K | — | Filing → |
| ARLZ | BUY | 2017-03-17 | $13K | — | Filing → |
| ARLZ | BUY | 2016-11-15 | $5K | — | Filing → |